Skip to content

Study of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation

Study of the Reduction of Anxiety After a Session of Energy Resonance by Cutaneous Stimulation in the Management of Patients Requiring Breast Macrobiopsy.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06056414
Acronym
MBRESC
Enrollment
57
Registered
2023-09-28
Start date
2024-01-08
Completion date
2025-07-09
Last updated
2026-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Neoplasm

Keywords

macrobiopsy, anxiety, Energy Resonance by Cutaneous Stimulation

Brief summary

Performing a breast macrobiopsy can be extremely delicate and anxiety-provoking. It can have an impact on the course of future examinations. Patients' emotional feelings also have a definite impact on the nursing staff. The purpose of the MBRESC study is to evaluate Energy Resonance by Cutaneous Stimulation , a manual acupressure technique, in the management of anxiety prior to breast macrobiopsy.

Interventions

OTHEREnergy Resonance by Cutaneous Stimulation

Energy Resonance by Cutaneous Stimulation session

Sponsors

Centre Henri Becquerel
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient has received full information on the organization and purpose of the research, and has signed an informed consent form. * Patient over 18 years of age * Patient undergoing a diagnostic breast macrobiopsy for suspected breast cancer * Patient undergoing a macro breast biopsy for the first time * Patient affiliated to or benefiting from a social security schem

Exclusion criteria

* Patient with a history of breast cancer or other pathologies requiring invasive procedures * Patient with several lesions to be biopsied * Patient with psychiatric pathology * Patient under anxiolytic or psychotropic treatment initiated in the month before the breast macrobiopsy

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the reduction in ANXIETY STATE1 dayEvaluation of anxiety before and after RESC session using Spielberger scale

Secondary

MeasureTime frameDescription
Evaluation of the reduction in ANXIETY STATE3 daysEvaluation of anxiety before and after RESC session using Spielberger scale

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026